Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood

Cytometry Part A

Volumn 89, Issue 3, 2016, Pages 259-270

  Lanuti, Paola ^a   Rotta, Gianluca ^b   Almici, Camillo ^c   Avvisati, Giuseppe ^d   Budillon, Alfredo ^e   Doretto, Paolo ^f   Malara, Natalia ^g   Marini, Mirella ^c   Neva, Arabella ^c   Simeone, Pasquale ^a   Di Gennaro, Elena ^e   Leone, Alessandra ^e   Falda, Alessandra ^f   Tozzoli, Renato ^f   Gregorj, Chiara ^d   Di Cerbo, Melania ^d   Trunzo, Valentina ^g   Mollace, Vincenzo ^g   Marchisio, Marco ^a   Miscia, Sebastiano ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b BD Biosciences Italia   (Italy)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

CD133; Circulating endothelial cells; Endothelial progenitor cells; Polychromatic flow cytometry; Vascular endothelial growth factor receptor 2

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; FLUORESCENT DYE; KDR PROTEIN, HUMAN; MCAM PROTEIN, HUMAN; PROM1 PROTEIN, HUMAN; PTPRC PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; AGED; BENCHMARKING; CELL COUNT; CHEMISTRY; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NORMAL HUMAN; PRACTICE GUIDELINE; STANDARDS;

AC133 ANTIGEN; ADOLESCENT; ADULT; AGED; ANTIGENS, CD146; ANTIGENS, CD34; ANTIGENS, CD45; BENCHMARKING; CELL COUNT; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; FLUORESCENT DYES; GENE EXPRESSION; HEALTHY VOLUNTEERS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84961391188     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22730     Document Type: Article

References (50)

1. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
3. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93:2951-2958.
4. Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GYH. Endothelial dysfunction and damage in congestive heart failure: Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 2004; 110:1794-1798.
5. Woywodt A, Schroeder M, Mengel M, Schwarz A, Gwinner W, Haller H, Haubitz M. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 2003; 41:720-723.
6. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97:3422-3427.
7. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106:571-578.
8. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105:71-77.
9. Farace F, Massard C, Borghi E, Bidart J-M, Soria J-C. Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells. Ann Oncol 2007; 18:1421-1422.
10. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97:3658-3661.
11. Moldovan NI, Moldovan L, Simionescu N. Binding of vascular anticoagulant alpha (annexin V) to the aortic intima of the hypercholesterolemic rabbit. An autoradiographic study. Blood Coagul Fibrinolysis 1994; 5:921-928.
12. Goon PKY, Boos CJ, Stonelake PS, Blann AD, Lip GYH. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost 2006; 96:45-52.
13. Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn H-J, Hamacher J, Boneberg E-M. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94:524-531.
14. Widemann A, Sabatier F, Arnaud L, Bonello L, Al-Massarani G, Paganelli F, Poncelet P, Dignat-George F. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J Thromb Haemost 2008; 6:869-876.
15. Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C, Braidotti P, Wu H-K, Zurita AJ, Saronni L, Cheng JB, Shalinsky DR, Heymach JV, Bertolini F. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: Flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15:267-273.
16. Strijbos MH, Kraan J, den Bakker MA, Lambrecht BN, Sleijfer S, Gratama JW. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry Part B Clin Cytom 2007; 72B:86-93.
17. Kraan J, Strijbos MH, Sieuwerts AM, Foekens JA, den Bakker MA, Verhoef C, Sleijfer S, Gratama JW. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost 2012; 10:931-939.
18. Lachmann R, Lanuti P, Miscia S. OMIP-011: Characterization of circulating endothelial cells (CECs) in peripheral blood. Cytometry Part A J Int Soc Anal Cytol 2012; 81A:549-551.
19. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95:952-958.
20. Kissa K, Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464:112-115.
21. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35:1109-1118.
22. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104:2752-2760.
23. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-1809.
24. Lee C-W, Huang P-H, Huang S-S, Leu H-B, Huang C-C, Wu T-C, Chen J-W, Lin S-J. Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy. Hypertens Res 2011; 34:999-1003.
25. Rossi F, Bertone C, Montanile F, Miglietta F, Lubrano C, Gandini L, Santiemma V. HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects. Microvasc Res 2010; 80:274-279.
26. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004; 107:273-280.
27. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, Stefano Di, Miccoli R, de Kreutzenberg R, Coracina S, Tiengo A, Agostini A, Del Prato C, Avogaro S. A, Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007; 50:2156-2163.
28. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45:1449-1457.
29. Lanuti P, Santilli F, Marchisio M, Pierdomenico L, Vitacolonna E, Santavenere E, Iacone A, Davì G, Romano M, Miscia S. A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: Relevance for the evaluation of endothelial dysfunction. J Immunol Methods 2012; 380:16-22.
30. Dercksen MW, Weimar IS, Richel DJ, Breton-Gorius J, Vainchenker W, Slaper-Cortenbach CM, Pinedo HM, von dem Borne AE, Gerritsen WR, van der Schoot CE. The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 1995; 86:3771-3782.
31. Eidenschink L, DiZerega G, Rodgers K, Bartlett M, Wells DA, Loken MR. Basal levels of CD34 positive cells in peripheral blood differ between individuals and are stable for 18 months. Cytometry Part B Clin Cytom 2012; 82B:18-25.
32. Lee KW, Blann AD, Lip GYH. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 2006; 111:302-308.
33. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005; 67:1078-1083.
34. Lee KW, Lip GYH, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105:526-532.
35. Fadini GP, Pagano C, Baesso I, Kotsafti O, Doro D, de Kreutzenberg SV, Avogaro A, Agostini C, Dorigo MT. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma. Acta Ophthalmol 2010; 88:135-141.
36. Foresta C, Ferlin A, Toni De, Lana L, Vinanzi A, Galan C, Caretta AN. Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction. Int J Impot Res 2015; 18:484-488.
37. Mund JA, Estes ML, Yoder MC, Ingram DA, Case J. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 2012; 32:1045-1053.
38. Kraan J, van den Broek P, Verhoef C, Grunhagen DJ, Taal W, Gratama JW, Sleijfer S. Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells. Br J Cancer 2014; 111:149-156.
39. Almici C, Skert C, Verardi R, Palma Di, Bianchetti A, Neva A, Braga A, Malagola S, Turra M, Marini A, Russo MD. Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease. Transplantation 2014;98:706-712.
40. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry Part A J Int Soc Anal Cytol 2006; 69A:1037-1042.
41. Perfetto SP, Ambrozak D, Nguyen R, Chattopadhyay PK, Roederer M. Quality assurance for polychromatic flow cytometry using a suite of calibration beads. Nat Protoc 2012; 7:2067-2079.
42. Perfetto SP, Ambrozak D, Nguyen R, Chattopadhyay P, Roederer M. Quality assurance for polychromatic flow cytometry. Nat Protoc 2006; 1:1522-1530.
43. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2:805-810.
44. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007; 27:1572-1579.
45. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007.
46. Mauro E, Rigolin GM, Fraulini C, Sofritti O, Ciccone M, Angeli De, Castoldi C, Cuneo GA. Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation. Eur J Haematol 2007; 78:374-380.
47. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109:337-346.
48. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schäfer B, Hossfeld DK, Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95:3106-3112.
49. Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Mohler ER. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry Part B Clin. Cytom 2006;70B:56-62.
50. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998; 273:30336-30343.